Sign Up to like & get
recommendations!
0
Published in 2019 at "Annals of hepatology"
DOI: 10.1016/j.aohep.2019.06.023
Abstract: INTRODUCTION AND OBJECTIVES The incidence of non-alcoholic fatty liver disease (NAFLD) is increasing. Previous studies indicated that Liraglutide, glucagon-like peptide-1 analogue, could regulate glucose homeostasis as a valuable treatment for Type 2 Diabetes. However, the…
read more here.
Keywords:
lc3 beclin1;
liraglutide;
hepg2 cells;
beclin1 atg7 ... See more keywords